Voya Investment Management LLC Has $192.85 Million Holdings in McKesson Co. (NYSE:MCK)

Voya Investment Management LLC lifted its holdings in shares of McKesson Co. (NYSE:MCK - Free Report) by 259.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 338,378 shares of the company's stock after acquiring an additional 244,315 shares during the quarter. Voya Investment Management LLC owned approximately 0.27% of McKesson worth $192,845,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of McKesson during the 4th quarter worth about $1,200,361,000. Marshall Wace LLP grew its position in shares of McKesson by 59,720.3% in the fourth quarter. Marshall Wace LLP now owns 358,922 shares of the company's stock valued at $204,553,000 after purchasing an additional 358,322 shares during the last quarter. Proficio Capital Partners LLC bought a new position in shares of McKesson during the fourth quarter worth approximately $178,397,000. Alliancebernstein L.P. lifted its holdings in McKesson by 46.6% during the 4th quarter. Alliancebernstein L.P. now owns 855,332 shares of the company's stock worth $487,462,000 after purchasing an additional 272,068 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new stake in McKesson in the 4th quarter valued at $128,125,000. Institutional investors own 85.07% of the company's stock.

McKesson Stock Up 0.9 %

Shares of NYSE MCK traded up $5.97 during midday trading on Tuesday, reaching $705.70. 203,070 shares of the company were exchanged, compared to its average volume of 889,951. The stock's 50-day moving average price is $663.22 and its 200-day moving average price is $609.22. The stock has a market cap of $88.44 billion, a P/E ratio of 32.33, a PEG ratio of 1.29 and a beta of 0.49. McKesson Co. has a one year low of $464.42 and a one year high of $728.32.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. On average, equities research analysts anticipate that McKesson Co. will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 3rd were given a dividend of $0.71 per share. The ex-dividend date was Monday, March 3rd. This represents a $2.84 annualized dividend and a yield of 0.40%. McKesson's dividend payout ratio is presently 13.00%.

Analyst Ratings Changes

A number of research firms have recently weighed in on MCK. UBS Group lifted their target price on McKesson from $708.00 to $805.00 and gave the stock a "buy" rating in a report on Tuesday. Cfra Research cut McKesson from a "moderate buy" rating to a "hold" rating in a research note on Friday, April 4th. StockNews.com lowered McKesson from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 14th. Mizuho upped their target price on McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a research report on Thursday, April 3rd. Finally, Morgan Stanley raised their price target on McKesson from $642.00 to $745.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Three equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $681.00.

Insiders Place Their Bets

In related news, CEO Brian S. Tyler sold 8,961 shares of the firm's stock in a transaction on Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the completion of the transaction, the chief executive officer now directly owns 60,664 shares of the company's stock, valued at $36,276,465.36. This trade represents a 12.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Leann B. Smith sold 188 shares of the company's stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the sale, the executive vice president now owns 1,051 shares in the company, valued at $640,679.09. This trade represents a 15.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 18,110 shares of company stock valued at $10,855,706 in the last ninety days. 0.11% of the stock is currently owned by insiders.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.